DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20194299

Ocular morbidity among diabetics attending the preventive ophthalmic clinic of a tertiary care institute with special reference to diabetic retinopathy

Anjum B. Fazili, Rohul J. Shah, Mohd D. Mir, Asif Jasmine, Feroz A. Wani, Beenish Mushtaq, Qazi M. Iqbal

Abstract


Background: Non communicable diseases have taken over previously life threatening infections in the demographic transition. As the burden of NCDs including diabetes is increasing at an alarming rate the complications related to these diseases are also increasing leading to huge morbidity. Likewise, blindness/ visual impairment due to diabetic retinopathy is now slowly and steadily replacing refractive errors and cataracts as a cause of morbidity.

Methods: This cross sectional study was carried over a period of one year in an ophthalmic unit of a tertiary health care institute in which known diabetic patients were screened for diabetic retinopathy besides various modifiable and non-modifiable risk factors.

Results: Overall prevalence of diabetic retinopathy in our study population was found to be 29.0%. Among various risk factors duration of diabetes, hypertension, HbA1C >6.5% and serum creatinine >1.1 mg/dl were found to be significantly associated with diabetic retinopathy.

Conclusion: Regular screening for diabetic retinopathy besides prevention and strict control of risk factors is key to prevention and progression of blindness/ visual impairment due to diabetic retinopathy.


Keywords


Diabetic retinopathy, Ocular Morbidity, Prevalence, Risk factors

Full Text:

PDF

References


Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14.

Prevention of Blindness from Diabetic Retinopathy. Report of a WHO Consultation, Geneva; November 2005.

Prokofyeva E, Zrenner E. Epidemiology of major eye diseases leading to blindness in Europe: a literature review. Ophthalmic Res 2012;47(4):171-88.

Stefánsson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000; 78(4):374-85.

Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527-32.

Kai S, Sarngal S, Ganjoo S. To study the prevalence of diabetic retinopathy in diabetes mellitus patients and its correlation with various associated risk factors. J Evol Medi Dental Scie. 2015;4(98):16341-6.

Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14(4):179-83.

Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090-101.

Qureshi T, Abdullah N, Shagufta. Prevalence of Diabetic retinopathy in Kashmir, India -A hospital based study. GJMEDPH 2013;2(1):1-6.

Gadkari SS, Maskati QB, Nayak BK. Prevalence of diabetic retinopathy in India: The All India Ophthalmological Society Diabetic Retinopathy Eye Screening Study 2014. Indian J Ophthalmol. 2016;64(1):38-44.

Idiculla J, Nithyanandam S, Joseph M, Mohan VKA, Vasu U, Sadiq M. Serum lipids and diabetic retinopathy: A crosssectional Study. Indian J Endocrinol Metab. 2012 Dec; 16(2): S492-4.

Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self-reported diabetics in Southern India: A population based assessment. Br J Ophthalmol. 2002;86:1014-8.

Raman R, Rani PK, Reddi Rachepalle S, Gnanamoorthy P, Uthra S, Kumaramanickavel G, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmol. 2009;116(2):311-8.

Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai urban rural epidemiology study (CURES) eye study, I. Invest Ophthalmol Vis Sci. 2005;46(7):2328-33.

Namperumalsamy P, Kim R, Vignesh TP, Nithya N, Royes J, Gijo T, et al. Prevalence and risk factors for diabetic retinopathy: A population based assessment from Theni District, South India. Postgrad Med J. 2009;85(1010):643-8.

Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in Southern India. Br J Ophthalmol. 1999;83(8):937-40.

Qoqonokana MQ, Brian G, Ramke J, Garcia J, Szetu J. Diabetic retinopathy in a hospital eye clinic in Soloman islands. Clin Experiment Ophthalmol 2010;38(9):862-6.

Jain IS. Vision threatening diabetic retinopathy. Ind J Ophthalmol. 1988;36(1):3.

Jost BS, Hilgemberg E, Rodrigues EB, Danoitti AF, Bonamigo EL. Prevalance of diabetic retinopathy in type 2 DM in the city of Luzarna Arg Bras Oftalmol 2010;73(3):259-65.

Javadi MA, Katibeh M, Rafati F, Dehghan MH, Zayeri F, Yaseri M, et al. Prevalence of diabetic retinopathy in Tehran province-Population based study. BMC Ophthalmology 2009;9(1):1471-2415.

Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, BEK T, Et al. Global Prevalence and Major Risk Factors of Diabetic Retinopathy. Diabetes Care. 2012;35(3):556-64.

Yanko L, Goldbourt U, Michaelson IC, Shapiro A, Yaari S. Prevalence and 15 year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol. 1983;67(11):759-65.

Kim CH, Hong SK, Park HJ, Yoon YH, Park JY, Lee UK. High serum lipoprotein (a) levels in Korean type 2 diabetes patients with proliferative diabetic retinopathy. Diabetes Care. 1998;21(12):2149-51.

Thomas RL, Dunstan F, Luzio SD, Roy Chowdury S, Hale SL, North RV, et al. Incidence of diabetic retinopathy in people with type 2 diabetes mellitusattending the diabetic retinopathy screening service for wales: retrospective analysis. BMJ. 2012;344:e874.

Jones CD, Greenwood RH, Misra A, Bachmann MO. Incidence andprogression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care. 2012;35(3):592-6.

Kajiwara A, Miyagawa H, Saruwatari J, Kita A, Sakata M, Kawata Y, et al. Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: a clinic-based retrospective longitudinal study. Diabetes Res Clin Pract. 2014;103(3):e7-10.

Romero-Aroca P, Baget-Bernaldiz M, Fernandez-Ballart J, Plana-Gil N, Soler-Lluis N, Mendez-Marin I, et al. Ten-year incidence of diabetic retinopathy and macular edema. Risk factors in a sample of people with type 1 diabetes. Diabetes Res Clin Pract. 2011;94(1):126-32.

Bajpai HS, Mehra KS, Singh VP, Tikko SK, Agrawal JK, Sharma A. Diabetic retinopathy: A clinico-biochemical study. Ind J Ophthalmol. 1979;27(3):12-5.

Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44(2):156-63.

Tudor SM, Hamman RF, Baron A, Johnson DW, Shetterly SM. Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado. Diabetes Care. 1998;21(1):53-61.

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703-13.

Chew EY, Klein ML, Ferris FL, Remaley NA, Murphy RP, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy. ETDRS Report 22. Arch Ophthalmol. 1996;144(9):1079-84.

Chopra R, Saramma JG, Mary J, Rebecca A. Lipoprotein (a) as a risk factor for diabetic retinopathy in patients with type 2 diabetes mellitus. Ind J Ophthalmol. 2007;55(3):195-8.

Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12(4):346-54.

Salinero-Fort MA, San Andres-Rebollo FJ, de Burgos-Lunar C, Arrieta-Blanco FJ, Gomez-Campelo P. Four-year incidence of diabetic retinopathy in a Spanish cohort: The Ma diabetes study. PLoS One. 2013;8(10):e76417.

Van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Blood pressure, lipids and obesity are associated with retinopathy. Diabetes Care. 2002;25:1320-25.

Wong TY, Liew G, Tapp RJ, Schmidt MI, Wang JJ, Mitchell P, et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet. 2008;371(9614):736-43.

King P, Peacock I, Donnelly R. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999 Nov; 48(5): 643-8.

Nathan DM for the DCCT/EDIC Research Group. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview. Diabetes Care. 2014 Jan; 37(1):9-16.